Outset Medical, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-18.0M | $-19.0M | $-19.5M | $-17.8M | $-18.5M | $-25.8M | $-25.6M | $-27.9M |
| Depreciation & Amortization | $627.0K | $795.0K | $881.0K | $1.0M | $1.2M | $1.3M | $1.4M | $1.4M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.7M | $3.5M | $4.1M | $5.1M | $3.5M | $3.0M | $4.9M | $6.4M |
| Net Cash from Operating Activities | $-9.6M | $-12.8M | $-9.5M | $-6.3M | $-4.8M | $-25.7M | $-16.5M | $-20.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $111.0K | $65.0K | $223.0K | $160.0K | $292.0K | $123.0K | $43.0K | $395.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $14.2M | $7.9M | $8.6M | $3.0M | $-31.2M | $-78.1M | $108.2M | $15.9M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-88.0K | $501.0K | $0 | $231.0K | $-384.0K | $55.7M | $-938.0K | $121.0K |
| Net Change in Cash | $4.4M | $-4.4M | $-931.0K | $-3.1M | $-36.4M | $-48.1M | $90.7M | $-4.6M |
| Free Cash Flow | $-9.7M | $-12.9M | $-9.7M | $-6.5M | $-5.1M | $-25.8M | $-16.5M | $-21.0M |